CRBP corbuspharma.com: Nilai Aset Bersih

Corbus Pharmaceuticals (CRBP) is experiencing a peak in recognition due to the outstanding results of its developments, which confirms the trajectory of its market capitalization, currently standing at 0.10. The business relies on outsourcing clinical trials and product manufacturing to reduce its own costs. High barriers to entry are created by formula patents and stringent drug safety oversight.

Kapitalisasi Buku: Corbus Pharmaceuticals Holdings (CRBP) kanggo 04.07.2022 - 29.10.2026

Corbus Pharmaceuticals Holdings - rincian analitis lan metrik utama (CRBP)

- rega saham lan prakiraan rega para ahli:

Bagan rega Corbus Pharmaceuticals, Inc.|CRBP - Bagan rega target

- data kapitalisasi saham perusahaan:

Biji pasar Corbus Pharmaceuticals Holdings, Inc.|CRBP - Nilai Perusahaan

- informasi kapitalisasi buku:

Nilai Buku Siji Saham Corbus Pharmaceuticals|CRBP - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku corbuspharma.com|CRBP - Aset Agregat Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Utang marang Ekuitas Corbus Pharmaceuticals|CRBP - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Corbus Pharmaceuticals Holdings, Inc.|CRBP - Utang perusahaan|Rasio utang marang aset resik Corbus Pharmaceuticals Holdings, Inc.|CRBP - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Corbus Pharmaceuticals

Analisis wiwitan perusahaan:Corbus Pharmaceuticals, Inc. CRBP

Institutional capital evaluates Corbus Pharmaceuticals (CRBP) through the lens of real net asset value. This calculation excludes market volatility, capturing the actual value of the issuer's assets. By analyzing the company's book capitalization chart, investors can see the objective trend of the fundamental basis. For Corbus Pharmaceuticals, this metric reflects resource stability while scaling the CRB-701 pipeline. A stable trend confirms the business's ability to fund expansion into targeted therapy.

Analisis pesaing Corbus Pharmaceuticals